• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后标志物 IL-8 的表达与乳腺癌中的免疫特征和上皮-间充质转化相关。

Expression of the prognostic marker IL-8 correlates with the immune signature and epithelial-mesenchymal transition in breast cancer.

机构信息

The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

J Clin Lab Anal. 2023 Feb;37(3):e24797. doi: 10.1002/jcla.24797. Epub 2023 Feb 1.

DOI:10.1002/jcla.24797
PMID:36725216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978063/
Abstract

BACKGROUND

IL-8 has been implicated in the malignant progression of various types of cancers; however, the precise molecular mechanisms associated with IL-8 in breast cancer (BRCA) are unclear.

METHODS

We analyzed the clinical signature and immune characteristics of BRCA patients and its correlation with IL-8 expression using The Cancer Genome Atlas (TCGA) datasets. The role of IL-8 in epithelial-mesenchymal transition (EMT) was verified through Western blotting, Cell Counting Kit-8 assay, and wound healing assays, as well as cell invasion experiments.

RESULTS

Through a comprehensive bioinformatics study, we determined that high IL-8 expression was associated with poor prognosis. Enrichment analysis revealed that high IL-8 expression was enriched in immune-related processes and cancer-related signaling pathways. In addition, IL-8 was associated with most of the immune-infiltrating cells, and high IL-8 expression indicated poor response to immunotherapy. Importantly, we found that IL-8 induced EMT in vitro.

CONCLUSIONS

Taken together, our data indicate that IL-8 may be a potential and valuable prognostic marker in BRCA, which may induce adverse outcomes by modulating the immune response and promoting EMT in BRCA patients.

摘要

背景

白细胞介素 8(IL-8)已被牵涉到多种类型癌症的恶性进展中;然而,与乳腺癌(BRCA)中 IL-8 相关的确切分子机制尚不清楚。

方法

我们使用癌症基因组图谱(TCGA)数据集分析了 BRCA 患者的临床特征和免疫特征及其与 IL-8 表达的相关性。通过 Western blot、细胞计数试剂盒-8 检测、划痕愈合实验和细胞侵袭实验验证了 IL-8 在上皮-间充质转化(EMT)中的作用。

结果

通过全面的生物信息学研究,我们确定高 IL-8 表达与预后不良有关。富集分析显示,高 IL-8 表达富集在免疫相关过程和癌症相关信号通路中。此外,IL-8 与大多数免疫细胞浸润有关,高 IL-8 表达表明对免疫治疗的反应不佳。重要的是,我们发现 IL-8 在体外诱导 EMT。

结论

综上所述,我们的数据表明,IL-8 可能是 BRCA 中一个有潜力和有价值的预后标志物,它可能通过调节免疫反应和促进 BRCA 患者的 EMT 来诱导不良后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/548854a83e04/JCLA-37-e24797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/2a3d1bf7f757/JCLA-37-e24797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/c89ffed93812/JCLA-37-e24797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/02845cb2273e/JCLA-37-e24797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/55815dee1c0d/JCLA-37-e24797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/b3dc1c0bb17c/JCLA-37-e24797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/548854a83e04/JCLA-37-e24797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/2a3d1bf7f757/JCLA-37-e24797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/c89ffed93812/JCLA-37-e24797-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/02845cb2273e/JCLA-37-e24797-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/55815dee1c0d/JCLA-37-e24797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/b3dc1c0bb17c/JCLA-37-e24797-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a0f/9978063/548854a83e04/JCLA-37-e24797-g001.jpg

相似文献

1
Expression of the prognostic marker IL-8 correlates with the immune signature and epithelial-mesenchymal transition in breast cancer.预后标志物 IL-8 的表达与乳腺癌中的免疫特征和上皮-间充质转化相关。
J Clin Lab Anal. 2023 Feb;37(3):e24797. doi: 10.1002/jcla.24797. Epub 2023 Feb 1.
2
Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.探讨乳腺癌上皮-间充质转化相关 lncRNA 特征和药物敏感性。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1154741. doi: 10.3389/fendo.2023.1154741. eCollection 2023.
3
BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.BRD7 通过负向调控 YB1 诱导的上皮-间充质转化抑制乳腺癌的侵袭和转移。
J Exp Clin Cancer Res. 2020 Feb 7;39(1):30. doi: 10.1186/s13046-019-1493-4.
4
Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.基于上皮-间质转化相关基因建立子宫内膜癌患者的预后标志物。
Front Immunol. 2022 Jan 14;12:805883. doi: 10.3389/fimmu.2021.805883. eCollection 2021.
5
High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.PDLIM2 高表达预示前列腺癌预后不良,并与上皮-间充质转化和免疫细胞浸润相关。
J Immunol Res. 2022 Jun 6;2022:2922832. doi: 10.1155/2022/2922832. eCollection 2022.
6
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.结直肠癌患者上皮-间质转化的基因组学与预后分析。
BMC Cancer. 2020 Nov 23;20(1):1135. doi: 10.1186/s12885-020-07615-5.
7
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.TEAD4 在膀胱癌中作为预后生物标志物,通过 PI3K/AKT 通路触发 EMT。
J Exp Clin Cancer Res. 2022 May 17;41(1):175. doi: 10.1186/s13046-022-02377-3.
8
The crosstalk between metabolic reprogramming and epithelial-mesenchymal transition and their synergistic roles in distant metastasis in breast cancer.代谢重编程与上皮-间充质转化的串扰及其在乳腺癌远处转移中的协同作用。
Medicine (Baltimore). 2024 Jun 14;103(24):e38462. doi: 10.1097/MD.0000000000038462.
9
Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.几丁质聚合因子促进乳腺癌细胞增殖、侵袭和迁移,并影响上皮-间充质转化相关标志物的表达。
FEBS Open Bio. 2021 Feb;11(2):423-434. doi: 10.1002/2211-5463.13062. Epub 2021 Jan 7.
10
Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.通过PI3K/Akt依赖性途径激活IL-8参与了人乳腺癌细胞中瘦素介导的上皮-间质转化。
Cancer Biol Ther. 2015;16(8):1220-30. doi: 10.1080/15384047.2015.1056409. Epub 2015 Jun 29.

引用本文的文献

1
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.
2
High IL-8 plasma levels at baseline are predictive of poor overall survival in breast cancer patients receiving chemotherapy.基线时血浆白细胞介素-8水平较高可预测接受化疗的乳腺癌患者总体生存期较差。
BMC Res Notes. 2025 Jul 9;18(1):283. doi: 10.1186/s13104-025-07353-6.
3
Expression of Interleukin-8, Interleukin-12 and Interleukin-13 in Esophageal Squamous Cell Carcinoma: Biomarker Potentiality and Prognostic Significance.

本文引用的文献

1
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.
2
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.上皮间质转化与肿瘤发生中的免疫应答。
Int J Mol Sci. 2021 Jul 9;22(14):7398. doi: 10.3390/ijms22147398.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
白细胞介素-8、白细胞介素-12 和白细胞介素-13 在食管鳞状细胞癌中的表达:生物标志物潜力和预后意义。
J Gastrointest Cancer. 2024 Sep;55(3):1239-1255. doi: 10.1007/s12029-024-01063-1. Epub 2024 Jun 23.
4
Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression.乳酸诱导的肿瘤相关成纤维细胞激活和 IL-8 介导的巨噬细胞募集促进肺癌进展。
Redox Biol. 2024 Aug;74:103209. doi: 10.1016/j.redox.2024.103209. Epub 2024 May 25.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment.TISCH:一个全面的网络资源,可实现肿瘤微环境中交互式单细胞转录组可视化。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1420-D1430. doi: 10.1093/nar/gkaa1020.
5
Tumor-infiltrating lymphocytes in the immunotherapy era.免疫治疗时代的肿瘤浸润淋巴细胞。
Cell Mol Immunol. 2021 Apr;18(4):842-859. doi: 10.1038/s41423-020-00565-9. Epub 2020 Nov 2.
6
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression.白细胞介素-8:癌症可塑性、血管生成和免疫抑制的交汇点的趋化因子。
Pharmacol Ther. 2021 Mar;219:107692. doi: 10.1016/j.pharmthera.2020.107692. Epub 2020 Sep 24.
7
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.癌症免疫疗法的历史与进展:了解肿瘤浸润免疫细胞的特征及其治疗意义。
Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1.
8
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.肿瘤微环境对免疫检查点阻断治疗的反应。
Front Immunol. 2020 May 7;11:784. doi: 10.3389/fimmu.2020.00784. eCollection 2020.
9
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy.免疫细胞和肿瘤微环境成像在免疫治疗新时代的相关性。
J Exp Clin Cancer Res. 2020 May 18;39(1):89. doi: 10.1186/s13046-020-01586-y.
10
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade.高系统和肿瘤相关的白细胞介素 8 与 PD-L1 阻断的临床获益降低相关。
Nat Med. 2020 May;26(5):693-698. doi: 10.1038/s41591-020-0860-1. Epub 2020 May 11.